J. Webb

发表

Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data.

W. Brown, P. Jacobs, D. Chitayat, 1999, American journal of medical genetics.

STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine

J. Webb, Lloyd Tannenbaum, Brannon L. Inman, 2021, The Journal of Emergency Medicine.

Microdeletions in FMR2 may be a significant cause of premature ovarian failure

A. Murray, G. Conway, J. Webb, 1999, Journal of medical genetics.

Microdeletions in FMR 2 may be a significant cause of premature ovarian failure

N. Morton, A. Murray, G. Conway, 1999 .

Studies of FRAXA and FRAXE in women with premature ovarian failure.

P. Jacobs, A. Murray, G. Conway, 1998, Journal of medical genetics.

Fragile X premutation screening in women with premature ovarian failure.

P. Jacobs, A. Murray, G. Conway, 1998, Human reproduction.

A familial case of X chromosome deletion ascertained by cytogenetic screening of women with premature ovarian failure.

A. Murray, G. Conway, P. Serhal, 1998, Human reproduction.

FRAXA and FRAXE in women with premature ovarian failure Table 2 Frequency of FRAXE alleles in the X chromosomes of 25 women with familial and 122 women with sporadic POF Allele Repeats Familial POF Sporadic POF Control

P. Jacobs, A. Murray, G. Conway, 2022 .

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.

N. Morton, A. Murray, G. Conway, 1999, Human reproduction.

Reproductive and menstrual history of females with fragile X expansions

N. Morton, A. Murray, S. Ennis, 2000, European Journal of Human Genetics.

Fragile X syndrome: of POF and premutations

P. Jacobs, A. Murray, J. Webb, 1999, Journal of medical genetics.